Systematic review of a patient care bundle in reducing staphylococcal infections in cardiac and orthopaedic surgery
Corresponding Author
Ning Ma
Royal Australasian College of Surgeons, Adelaide, South Australia, Australia
Correspondence
Mr Ning Ma, Royal Australasian College of Surgeons, 199 Ward Street, North Adelaide, SA 5006, Australia. E-mail: [email protected]
Search for more papers by this authorAlun Cameron
Royal Australasian College of Surgeons, Adelaide, South Australia, Australia
Search for more papers by this authorDavid Tivey
Royal Australasian College of Surgeons, Adelaide, South Australia, Australia
Search for more papers by this authorNikki Grae
New Zealand Health Quality & Safety Commission, Wellington, New Zealand
Search for more papers by this authorSally Roberts
Auckland District Health Board, Auckland, New Zealand
Search for more papers by this authorArthur Morris
Auckland District Health Board, Auckland, New Zealand
Search for more papers by this authorCorresponding Author
Ning Ma
Royal Australasian College of Surgeons, Adelaide, South Australia, Australia
Correspondence
Mr Ning Ma, Royal Australasian College of Surgeons, 199 Ward Street, North Adelaide, SA 5006, Australia. E-mail: [email protected]
Search for more papers by this authorAlun Cameron
Royal Australasian College of Surgeons, Adelaide, South Australia, Australia
Search for more papers by this authorDavid Tivey
Royal Australasian College of Surgeons, Adelaide, South Australia, Australia
Search for more papers by this authorNikki Grae
New Zealand Health Quality & Safety Commission, Wellington, New Zealand
Search for more papers by this authorSally Roberts
Auckland District Health Board, Auckland, New Zealand
Search for more papers by this authorArthur Morris
Auckland District Health Board, Auckland, New Zealand
Search for more papers by this authorAbstract
Surgical site infections (SSIs) are serious adverse events hindering surgical patients’ recovery. In Australia and New Zealand, SSIs are a huge burden to patients and healthcare systems. A bundled approach, including pre-theatre nasal and/or skin decolonization has been used to reduce the risk of staphylococcal infection. The aim of this review is to assess the effectiveness of the bundle in preventing SSIs for cardiac and orthopaedic surgeries. The review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Published literature was searched in PubMed, Embase and Cochrane Library of Systematic reviews. Identified articles were selected and extracted based on a priori defined Population-Intervention-Comparator-Outcome and eligibility criteria. Data of randomized controlled trials (RCTs) and comparative observational studies were synthesized by meta-analyses. Quality appraisal tools were used to assess the evidence quality. The review included six RCTs and 19 observational studies. The bundled treatment regimens varied substantially across all studies. RCTs showed a trend of Staphylococcus aureus SSIs reduction due to the bundle (relative risk = 0.59, 95% confidence interval (CI) = 0.33, 1.06) with moderate heterogeneity. Observational studies showed statistically significant reduction in all-cause and S. aureus SSIs, with 51% (95% CI = 0.41, 0.59) and 47% (95% CI = 0.35, 0.65), respectively. No publication biases were detected. SSIs in major cardiac and orthopaedic surgeries can be effectively reduced by approximately 50% with a pre-theatre patient care bundle approach.
Supporting Information
Filename | Description |
---|---|
ans13879-sup-0001-FigureS1.tiffTIFF image, 273.5 KB | Figure S1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses chart for study selection. |
ans13879-sup-0002-FigureS2.tiffTIFF image, 144.1 KB | Figure S2. Risk of bias for all randomized controlled trials. |
ans13879-sup-0003-FigureS3.tiffTIFF image, 122.5 KB | Figure S3. Risk of bias summary for randomized controlled trials. |
ans13879-sup-0004-TableS1-2.docxWord 2007 document , 25.2 KB |
Table S1. Population-Intervention-Comparator-Outcome criteria. Table S2. Quality assessment of observational studies (study post-2013). |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- 1Schweizer M, Perencevich E, McDanel J et al. Effectiveness of a bundled intervention of decolonization and prophylaxis to decrease Gram positive surgical site infections after cardiac or orthopedic surgery: systematic review and meta-analysis. BMJ 2013; 346: f2743.
- 2Nicholls TM, Morris AJ. Nosocomial infection in Auckland Healthcare hospitals. N. Z. Med. J. 1997; 110: 314–6.
- 3 Australian Commission on Safety and Quality in Health Care. Surgical Site Infection (SSI) Definition, 2004. [Cited 19 Jul 2016.] Available from URL: http://www.safetyandquality.gov.au/wp-content/uploads/2012/01/ssidefine05.pdf
- 4Graves N, Nicholls TM, Morris AJ. Modeling the costs of hospital-acquired infections in New Zealand. Infect. Control Hosp. Epidemiol. 2003; 24: 214–23.
- 5 Australian Commission on Safety and Quality in Health Care. Healthcare Associated Infection Action Guide, 2012. [Cited 19 Jul 2016.] Available from URL: http://www.safetyandquality.gov.au/wp-content/uploads/2012/08/1.2-Healthcare-Associated-Infection.pdf
- 6Graf K, Sohr D, Haverich A, Kuhn C, Gastmeier P, Chaberny IF. Decrease of deep sternal surgical site infection rates after cardiac surgery by a comprehensive infection control program. Interact. Cardiovasc. Thorac. Surg. 2009; 9: 282–6.
- 7Wassenberg MW, de Wit GA, Bonten MJ. Cost-effectiveness of preoperative screening and eradication of Staphylococcus aureus carriage. PLoS One 2011; 6: e14815.
- 8Kallen AJ, Wilson CT, Larson RJ. Perioperative intranasal mupirocin for the prevention of surgical-site infections: systematic review of the literature and meta-analysis. Infect. Control Hosp. Epidemiol. 2005; 26: 916–22.
- 9Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int. J. Surg 2010; 8: 336–41.
- 10Higgins JP, Altman DG, Gotzsche PC et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928.
- 11Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J. Epidemiol. Community Health 1998; 52: 377–84.
- 12Viechtbauer W. Conducting meta-analyses in R with the metafor package. J. Stat. Softw. 2010; 36: 1–48.
- 13Bode LG, Kluytmans JA, Wertheim HF et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N. Engl. J. Med. 2010; 362: 9–17.
- 14Sousa RJ, Barreira PM, Leite PT, Santos AC, Ramos MH, Oliveira AF. Preoperative Staphylococcus aureus screening/decolonization protocol before total joint arthroplasty – results of a small prospective randomized trial. J. Arthroplasty 2016; 31: 234–9.
- 15Segers P, Speekenbrink RG, Ubbink DT, van Ogtrop ML, de Mol BA. Prevention of nosocomial infection in cardiac surgery by decontamination of the nasopharynx and oropharynx with chlorhexidine gluconate: a randomized controlled trial. JAMA 2006; 296: 2460–6.
- 16Konvalinka A, Errett L, Fong IW. Impact of treating Staphylococcus aureus nasal carriers on wound infections in cardiac surgery. J. Hosp. Infect. 2006; 64: 162–8.
- 17Kalmeijer MD, Coertjens H, van Nieuwland-Bollen PM et al. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin. Infect. Dis. 2002; 35: 353–8.
- 18Phillips M, Rosenberg A, Shopsin B et al. Preventing surgical site infections: a randomized, open-label trial of nasal mupirocin ointment and nasal povidone-iodine solution. Infect. Control Hosp. Epidemiol. 2014; 35: 826–32.
- 19Adler AL, Martin ET, Cohen G et al. A comprehensive intervention associated with reduced surgical site infections among pediatric cardiovascular surgery patients, including those with delayed closure. J. Pediatr. Infect. Dis. Soc. 2012; 1: 35–43.
- 20Baratz MD, Hallmark R, Odum SM, Springer BD. Twenty percent of patients may remain colonized with methicillin-resistant Staphylococcus aureus despite a decolonization protocol in patients undergoing elective total joint arthroplasty. Clin. Orthop. Relat. Res. 2015; 473: 2283–90.
- 21Bebko SP, Green DM, Awad SS. Effect of a preoperative decontamination protocol on surgical site infections in patients undergoing elective orthopedic surgery with hardware implantation. JAMA Surg. 2015; 150: 390–5.
- 22Cimochowski GE, Harostock MD, Brown R, Bernardi M, Alonzo N, Coyle K. Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics. Ann. Thorac. Surg. 2001; 71: 1572–8.
- 23Gernaat-van der Sluis AJ, Hoogenboom-Verdegaal AM, Edixhoven PJ, Spies-van Rooijen NH. Prophylactic mupirocin could reduce orthopedic wound infections. 1,044 patients treated with mupirocin compared with 1,260 historical controls. Acta Orthop. Scand. 1998; 69: 412–4.
- 24Jog S, Cunningham R, Cooper S et al. Impact of preoperative screening for meticillin-resistant Staphylococcus aureus by real-time polymerase chain reaction in patients undergoing cardiac surgery. J. Hosp. Infect. 2008; 69: 124–30.
- 25Katayanagi T. Nasal methicillin-resistant S. aureus is a major risk for mediastinitis in pediatric cardiac surgery. Ann. Thorac. Cardiovasc. Surg. 2015; 21: 37–44.
- 26Kim DH, Spencer M, Davidson SM et al. Institutional prescreening for detection and eradication of methicillin-resistant Staphylococcus aureus in patients undergoing elective orthopaedic surgery. J. Bone Joint Surg. Am. 2010; 92: 1820–6.
- 27Kluytmans JA, Mouton JW, VandenBergh MF et al. Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus. Infect. Control Hosp. Epidemiol. 1996; 17: 780–5.
- 28Kohler P, Sommerstein R, Schonrath F et al. Effect of perioperative mupirocin and antiseptic body wash on infection rate and causative pathogens in patients undergoing cardiac surgery. Am. J. Infect. Control 2015; 43: e33–8.
- 29Martorell C, Engelman R, Corl A, Brown RB. Surgical site infections in cardiac surgery: an 11-year perspective. Am. J. Infect. Control 2004; 32: 63–8.
- 30Nicholson MR, Huesman LA. Controlling the usage of intranasal mupirocin does impact the rate of Staphylococcus aureus deep sternal wound infections in cardiac surgery patients. Am. J. Infect. Control 2006; 34: 44–8.
- 31Price CS, Williams A, Philips G, Dayton M, Smith W, Morgan S. Staphylococcus aureus nasal colonization in preoperative orthopaedic outpatients. Clin. Orthop. Relat. Res. 2008; 466: 2842–7.
- 32Rao N, Cannella BA, Crossett LS, Yates AJ Jr, McGough RL III, Hamilton CW. Preoperative screening/decolonization for Staphylococcus aureus to prevent orthopedic surgical site infection: prospective cohort study with 2-year follow-up. J. Arthroplasty 2011; 26: 1501–7.
- 33Sankar B, Hopgood P, Bell KM. The role of MRSA screening in joint-replacement surgery. Int. Orthop. 2005; 29: 160–3.
- 34Schweizer ML, Chiang HY, Septimus E et al. Association of a bundled intervention with surgical site infections among patients undergoing cardiac, hip, or knee surgery. JAMA 2015; 313: 2162–71.
- 35Walsh EE, Greene L, Kirshner R. Sustained reduction in methicillin-resistant Staphylococcus aureus wound infections after cardiothoracic surgery. Arch. Intern. Med. 2011; 171: 68–73.
- 36Wilcox MH, Hall J, Pike H et al. Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections. J. Hosp. Infect. 2003; 54: 196–201.
- 37Hadley S, Immerman I, Hutzler L, Slover J, Bosco J. Staphylococcus aureus decolonization protocol decreases surgical site infections for total joint replacement. Arthritis 2010; 2010: 924518.
- 38Chen AF, Wessel CB, Rao N. Staphylococcus aureus screening and decolonization in orthopaedic surgery and reduction of surgical site infections. Clin. Orthop. Relat. Res. 2013; 471: 2383–99.
- 39Hacek DM, Robb WJ, Paule SM, Kudrna JC, Stamos VP, Peterson LR. Staphylococcus aureus nasal decolonization in joint replacement surgery reduces infection. Clin. Orthop. Relat. Res. 2008; 466: 1349–55.
- 40Mathur P, Trikha V, Farooque K et al. Implementation of a short course of prophylactic antibiotic treatment for prevention of postoperative infections in clean orthopaedic surgeries. Indian J. Med. Res. 2013; 137: 111–6.
- 41Levy PY, Ollivier M, Drancourt M, Raoult D, Argenson JN. Relation between nasal carriage of Staphylococcus aureus and surgical site infection in orthopedic surgery: the role of nasal contamination. A systematic literature review and meta-analysis. Orthop. Traumatol. Surg. Res. 2013; 99: 645–51.
- 42Lador A, Nasir H, Mansur N et al. Antibiotic prophylaxis in cardiac surgery: systematic review and meta-analysis. J. Antimicrob. Chemother. 2012; 67: 541–50.
- 43Davies BM, Jones A, Patel HC. Implementation of a care bundle and evaluation of risk factors for surgical site infection in cranial neurosurgery. Clin. Neurol. Neurosurg. 2016; 144: 121–5.
- 44Schaffzin JK, Harte L, Marquette S et al. Surgical site infection reduction by the solutions for patient safety hospital engagement network. Pediatrics 2015; 136: e1353–60.
- 45Caffrey AR, Woodmansee SB, Crandall N et al. Low adherence to outpatient preoperative methicillin-resistant Staphylococcus aureus decolonization therapy. Infect. Control Hosp. Epidemiol. 2011; 32: 930–2.
- 46Rodriguez-Merchan EC. Screening and decolonization of MRSA among joint arthroplasty patients: efficacy, cost-effectiveness and durability. J. Acute Dis. 2014; 3: 218–20.
10.1016/S2221-6189(14)60048-2 Google Scholar
- 47 Health Quality & Safety Commission New Zealand. Cardiac Surgery Implementation Manual. Wellington: Health Quality & Safety Commission New Zealand, 2014.
- 48 Health Quality & Safety Commission New Zealand. Orthopaedics Surgery Implementation Manual. Wellington: Health Quality & Safety Commission New Zealand, 2014.
- 49 National Health and Medical Research Council. Australian Guidelines for the Prevention and Control of Infection in Healthcare. Canberra: Commonwealth of Australia, 2010.